Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve This is to inform that a meeting of ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, February 9, 2026 to consider, approve and take on record the unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26 and 9M FY26). This is a routine regulatory intimation under SEBI Listing Regulations. The trading window for insiders has been closed from close of business on December 31, 2025 until 48 hours after the results are made public on February 9, 2026. No financial figures or details have been disclosed in this notice — only the schedule of the upcoming board meeting.
This is a standard advance notice with no material information for investors yet. Shareholders should watch for the actual Q3 FY26 results on February 9, 2026, which will reveal the company's quarterly revenue, profit, and margin performance and could move the stock depending on the numbers versus expectations.